Anzu Partners

We are a Venture Capital firm founded by leading experts in the fields of science, technology, medicine, business, and finance. We are initially focused on global medical technology. With over 40 patents and multiple successful ventures amongst the founders, we have a proven track record of astute medical and technology investment management. We don't just invest, we build, nurture and curate our community of ventures to be the best they can. We believe that with an increasing global population, an aging and ailing population in developed economies and with increases in non-communicable diseases, there exists a unique opportunity for investors to capitalise on high growth medical technology and life sciences that will not only drive high returns for investors but make the world a better place through improved quality of life.

We are a European family office owned fund; we understand biosciences and medical technologies better than anyone else in the Private Equity and Venture Capital ecosystem. The capital of this fund has been generated by the family office's active bioscience investments across Europe, USA, and the APAC region since 1995. We understand the intricacies of commercializing bioscience discoveries. We also acknowledge that bioscience venture leadership requires deep courage - from founders and the investors that back them. What we look for We operate globally and only review investment opportunities submitted to us by our partner investment banks across the globe. If we believe in the transformative power of the discovery and the founder's ambition, this will suffice for us to determine the venture's potential. Our approach Upon receipt of a proposal from our investment bank partners, we will analyze the proposed deal, meet with the venture founders, and understand their vision. We will propose a deal size and structure. Execute a letter of intent and perform appropriate due diligence, negotiate, and execute a mutually acceptable binding contract. Release the required funding, close the transaction and work together to grow the business.

Portal Innovations is a venture capital firm that helps exceptional life sciences innovators build their companies where they live. We surround these entrepreneurs with the resources and community they need: Seed capital, fully equipped lab space, and expertise and introductions to other investors and partners. Our crafted capital™ approach provides management expertise, funding, and lab+work space to turn breakthroughs into businesses. The Problem Entrepreneurs struggle and VC firms miss investment opportunities when exceptional scientific innovators do not have the capital, lab space and management skills to grow new life sciences companies where they live. Many of these missed investments are due to the lack of relationships between universities and VCs. Our Approach For top life science innovators in emerging biotech ecosystems, we offer a clear path for them to bring their ambitions closer to reality and achieve their next round of funding. First, we provide things that are scarce: Early-stage funding, fully equipped lab space, and introductions to our trusted, global network - all built on the real-world experiences of our founders, who have taken several life sciences startups public and raised more than $750 million in venture capital. Second, investors are being drawn to these emerging markets by exceptional faculty at top-tier academic research institutions. Portal is the first mover in these emerging markets, identifying the most promising life sciences technologies and innovators through our university relationships. We then partner with our network of investors and corporations to support these startups together. Third, Portal has a number of scientists on staff to help with consulting services for our portfolio companies. Whether it’s creating a go-to-market strategy, or analyzing scientific data, we’re here to help and facilitate success in life sciences. Portal by the numbers32: number of member companies in Chicago 50,000: total square feet of lab and office space $6M: worth of world-class lab equipment 80%+ equipment needs we aim to provide to member companies From potential to performance. Our market-based approach identifies the most promising life science startups, and supports them throughout the journey. We engage deeply in every aspect of the business, leveraging our network to tackle each company’s specific challenges and lead them to successful Series A investments with world-class VCs and strategic investors. Assess We begin with a deep dive into the prospect company to examine management and strategic needs, leadership team, space requirements, and current funding. At every turn, we’re assessing opportunity and fit. Rigorous research and market understanding Seeking emerging technologies and novel approaches to big problems Build portfolio of high-potential biopharma, med tech, and data sciences ventures Invest Once selected, we begin our collaboration with company founders. We understand the many complexities of the biotech business model, and bring deep experience to help startups answer defining strategic questions, overcome roadblocks, and build capability and confidence. Support key regulatory and clinical decisions Optimize manufacturing and commercial considerations Build In the build stage, we work side-by-side with company founders to nurture and accelerate growth. We craft a robust strategic roadmap for value creation, and execute together with urgency and action. 12–18 months Vested interest in growth and value creation Best-in-class business operations, financial and strategic partnerships, and lab equipment Evolve From day one, we work with the end game in mind: prosperous execution. We guide our portfolio companies toward the most favorable next step in their journey, be it acquisition or strategic partnership. Expertise, partnership, and trust to drive successful outcomes Lasting, positive impact

Biospring Partners was founded in 2020 to invest in companies with the potential to fundamentally shift how technology is utilized across the life sciences sector. Michelle Dipp and Jennifer Lum came together to combine their experience in healthcare, technology, investing and operations to offer a differentiated approach to growth equity. Expanding the potential of life sciences technology We focus on identifying long-term themes within life sciences technology. We build trusted partnerships with management teams to support the growth of their businesses. Sectors we invest in Biospring invests in growth-stage B2B companies that are driving innovation across the life sciences industry and beyond. Our Approach We are a trusted partner that thrives in building long term strategic partnerships. We work closely alongside our companies to broaden their ambition and strengthen their path to growth. Our Investment Criteria$10M+ in annual revenue 30%+ revenue growth Diverse customer base

We’re not just an investor. We’re all about being an active stakeholder. Identify: We are renown for identifying early stage technologies and start-ups. Our established network and expertise enable us to do so. Incubate: We run an incubation center for our early stage start-ups that need support in early growth stage. Accelerate: We act as business development managers for our portfolio companies. We help companies collaborate in the bio-ecosystem. Funding to IPO: We back our portfolio companies in the long run. We accompany them from the very start to their success. We take entrepreneurial ideas into reality. We have been investing in the past, present and into the future. Korea to Global: Using our global pharmaceutical network we source licensing & research collaboration deals for our portfolios. Korea to China: Through collaboration with our network in China we help value up our portfolio companies. Each year we host ‘China Korea Bio Business Networking Day’ to connect Korean biotechs with Chinese pharmaceuticals and buy-side investors. Korea to Vietnam: We invest in local Vietnam start-ups and build up platforms, formulate ecosystems to accommodate the growth of future industries. And beyond… We are creators and path makers We create synergy, matrix and we take the first step for others to follow.

Through its activities, Technology Ventures facilitates promising inventions to improve the quality of life for patients around the world. The mission of Technology Ventures is to promote the commercial development of Cedars‑Sinai research into products and services that advance healthcare and improve patient wellbeing. Technology Ventures actively seeks industry partners to develop these technologies and works to establish mutually beneficial long‑term relationships.